ArticleDigital health
P-MES: Explainable pathology-based distant metastasis risk stratification in locally advanced nasopharyngeal carcinoma.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite substantial therapeutic progress, distant metastasis (DM) persists as the leading cause of treatment failure and a critical driver of poor survival in nasopharyngeal carcinoma (NPC). Existing prognostic tools remain limited in accuracy and clinical utility, underscoring the need for more robust and actionable biomarkers. The convergence of artificial intelligence (AI) and digital pathology offers a promising avenue by enabling the extraction of prognostic signatures directly from routinely available histopathology. In this study, we developed and validated a deep learning (DL) model based on whole slide images (WSIs) to predict post-treatment DM risk in patients with locally advanced NPC. Methods: We developed the Pathology-based distant metastasis risk stratification model (P-MES) using WSIs from 147 NPC patients. WSIs were encoded into patch-level embeddings using the pretrained UNI feature extractor, followed by multiple instance learning (MIL) aggregation to generate slide-level representations for predicting DM. To enhance interpretability, attention-based heatmaps were generated, and complementary morphologic features extracted by CellProfiler were used to elucidate histopathologic patterns associated with metastatic risk. Results: P-MES achieved excellent predictive performance in the training, validation, and internal test sets (AUCs: 0.990, 0.887, and 0.949), demonstrating substantial discrimination, calibration, and clinical net benefit. CellProfiler analysis further identified ten morphology-derived features associated with DM. Conclusion: P-MES is an automated, pathology-based framework for predicting DM in NPC, providing pathological insights and supporting personalized clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.